AdaptHealth Corp. (AHCO), a leading provider of home healthcare equipment and services, saw its stock price surge by 5.08% during intraday trading on Wednesday, February 26th, 2025. The company's strong performance can be attributed to its impressive fourth-quarter 2024 results and positive outlook for 2025, as highlighted in its recent earnings release.
In the fourth quarter of 2024, AdaptHealth reported flat revenue compared to the prior year quarter, but exceeded the midpoint of its guidance by 3%. The Sleep Health and Respiratory Health segments demonstrated year-over-year growth, with Sleep Health revenue increasing by 3.4% and Respiratory Health revenue rising by 1%. While the Diabetes Health segment experienced a 7.3% decline in revenue, the company's adjusted EBITDA and free cash flow exceeded the high end of its guidance ranges.
For the full year 2024, AdaptHealth achieved revenue of $3.26 billion, representing a 1.9% increase over the previous year. The company's adjusted EBITDA grew by 2.7% to $688.7 million, and its net leverage ratio improved to 2.8 times, thanks to a $170 million reduction in debt during the year.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。